Emmanuel Hui

Emmanuel Hui is helping to reshape Hong Kong’s biomedical innovation landscape. At the Tiger Jade Pebble Accelerator, also known as Pebble, he guides portfolio companies from academic research into clinical reality—backed by Tigermed, China’s largest clinical contract-research organisation, alongside investors including Nan Fung and Morningside. In collaboration with major hospitals and universities across the city, Pebble supports more than 20 companies, including women’s health biotech Heranova, Pilatus Biosciences and medtech start-up Opharmic Technology. Through his parallel venture fund Saltagen Ventures, Emmanuel is also raising an institutional fund to back transpacific innovations, while teaching at the Chinese University of Hong Kong.